Transcript - Indian Innovation Forum 2013 - Dr Shubhada Chiplunkar
Dr Shubhada Chiplunkar, Director of ACTREC - The Advanced Centre for Treatment, Research and Education in Cancer
Download alternative video format (MOV, 9.7MB)
I’m Dr Shubhada Chiplunkar and I’m the Director of the Advance Centre for Treatment, Research and Education in Cancer; the acronym is ACTREC. It’s under the Tata Memorial Centre and is one of the leading research organisations of the country, dedicated to both basic and translational cancer research.
We have a very unique model at ACTREC. We have a basic research wing and a clinical research wing, and I say it’s unique because this does not exist, that under one roof you have both basic and clinical research going on. And people are working in several aspects of cancer biology, cell biology addressing questions to common malignancies of the country. There are many areas of common interest, having gone through the information which was given to us, and of course what we know through literature, I think there’s a lot of work going on in addressing through the genomics, as I said, and these are going to evolve into biomarkers, future biomarkers.
But as I mentioned, the malignancies which are more important to India, like we have a very high incidence now coming up of the gall bladder cancer. We would like to address these issues. Of course there are common interests like prostate cancer or, for that matter, ovarian cancer where Australians have done very well and this would be a nice platform for collaboration in these areas too.
[END RECORDING / END TRANSCRIPT]